SAN DIEGO (AP) — SAN DIEGO (AP) — Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $30.2 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of 62 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

For the year, the company reported a loss of $105 million, or $2.26 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR